EVNIN LUKE sold 18.5% of their position (141.11K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $66.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/29/2026ACC: 0001134657-26-000015
Director10% Owner
Since Apr 2021
-141.11K
Net shares
Net seller
$66.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
141.11K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−80.85K
Price / share
$0.48
Trade value
$38.81K
% of position
10.6%
5/27/2026
763.68K→682.83K
Common Stock
Indirect
Shares
−27.70K
Price / share
$0.46
Trade value
$12.74K
% of position
4.1%
5/28/2026
682.83K→655.13K
Common Stock
Indirect
Shares
−32.56K
Price / share
$0.45
Trade value
$14.65K
% of position
5.0%
5/29/2026
655.13K→622.58K
Total
Net shares
−141.11K
Net value
-$66.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/27/2026 | S · Sale | −80.85K | $0.48 | $38.81K | 10.6% | 763.68K | 682.83K |
| Common Stock Indirect | 5/28/2026 | S · Sale | −27.70K | $0.46 | $12.74K | 4.1% | 682.83K | 655.13K |
| Common Stock Indirect | 5/29/2026 | S · Sale | −32.56K | $0.45 | $14.65K | 5.0% | 655.13K | 622.58K |
| Total | −141.11K | -$66.20K | ||||||
Derivative Transactions0
No derivative transactions reported